Open AccessEtravirine–raltegravir, a marked interaction in HIV-1-infected patients: about four cases
Author(s) -
Amélie Ménard,
Caroline Solas,
Saadia Mokthari,
Sylvie Brégigeon,
Marie-Pierre Drogoul,
Catherine Tamalet,
Bruno Lacarelle,
Isabelle Martin
Publication year - 2009
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328329915f
Subject(s) - etravirine , raltegravir , darunavir , ritonavir , enfuvirtide , amprenavir , therapeutic drug monitoring , elvitegravir , reverse transcriptase inhibitor , efavirenz , medicine , indinavir , pharmacology , saquinavir , pharmacokinetics , integrase inhibitor , glucuronidation , viral load , lamivudine , virology , human immunodeficiency virus (hiv) , chemistry , immunology , antiretroviral therapy , hiv 1 protease , virus , hepatitis b virus , protease , microsome , enzyme , epitope , biochemistry , gp41 , antigen